A recent symposium sponsored by Alflorex at the Royal Society of Medicine in London focused on new approaches to a range of digestive health issues.
The symposium, held at the Royal Society of Medicine in London,was chaired by Dr. Ayesha Akbar and attended by some of the UK’s leading gastroenterologists. Attendees discussed presentations by an international panel of experts. This included discussion of the clinical trial data on the 35624® culture in Alflorex®, which has been shown to reduce symptoms of bloating, abdominal pain, gas and unpredictable bowel movements such as alternating diarrhoea and constipation. The panel consisted of:
Dr. Anton Emmanuel
Dr. Anton Emmanuel is a Senior Lecturer in Neuro-Gastroenterology and Consultant Gastroenterologist at UCL and the National Hospital for Neurology and Neurosurgery. He is the Medical Director of Core, the largest UK gastrointestinal charity and the Editor of the journal Frontline Gastroenterology.
Professor Qasim Aziz
Professor Qasim Aziz is Professor of Neurogastroenterology at St Bartholomew's Hospital and The London NHS Trust and director of the Wingate Institute of Neurogastroenterology.
Professor Eamonn Quigley
Professor Eamonn Quigley is the Chief of Gastroenterology at The Methodist Hospital in Houston. He has served as president of both the American College of Gastroenterology and the World Gastroenterology Organisation and is a past editor-in-chief of the American Journal of Gastroenterology.
Dr. Ayesha Akbar
Dr. Ayesha Akbar is a Consultant Gastroenterologist at St. Marks Hospital London. She is the chair of the Neurogastroenterology committee of the British Society of Gastroenterology.
Special thanks to all who attended.
If you are interested in finding out more about the evidence behind Alflorex® and the Bifidobacterium longum 35624® culture click here for a list of clinical studies and publications. or contact email@example.com for more information.